Arcutis Biotherapeutics, Inc. is launching a new virtual health platform designed to expand access pathways to its roflumilast (Zoryve) portfolio for chronic inflammatory skin diseases.
The virtual health platform provides individuals living with atopic dermatitis (AD), seborrheic dermatitis (SebDerm), and plaque psoriasis (PsO) with an additional pathway to connect with independent, board-certified dermatologists and access care through a streamlined digital experience.
The offering is intended to complement traditional in-office dermatology specialist care with an alternative pathway to a dermatologist for those who have yet to see a dermatologist or who struggle with obtaining timely dermatology care. The platform connects individuals with independent dermatologists after completing a brief clinical intake.
“At Arcutis, we believe meaningful innovation should not be focused solely on new treatments, but should extend to all aspects of dermatology care, including access to dermatologists,” says Todd Edwards, Chief Commercial Officer of Arcutis, in a news release. “We recognize that individuals living with chronic inflammatory skin diseases have different preferences for how and when they engage with providers, and many patients struggle to obtain in-person dermatology care.
“Our virtual health platform is designed to complement traditional care settings by helping reduce barriers to specialist treatment and supporting individuals who may otherwise forego or face delays in seeing a dermatologist. By providing an additional option for individuals to connect with an independent dermatologist, we can help individuals access timely care and determine whether ZORYVE may be right for them.”
Board-certified, independent dermatologists participating in the platform evaluate, diagnose, and determine appropriate treatment for each individual based on their clinical judgment. Arcutis does not influence clinical decision-making, diagnoses, or prescribing decisions made through the platform. If prescribed, roflumilast prescriptions are coordinated through a national pharmacy hub designed to support a seamless experience, including insurance support and home delivery, or prescriptions can be sent directly to an individual’s preferred pharmacy.